Lisa Lancaster

Jun 27, 2024 | bmjopenrespres.bmj.com | Steven Nathan |Jürgen Behr |Vincent Cottin |Lisa Lancaster

Interstitial lung disease Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service.

Jun 27, 2024 | bmjopenrespres.bmj.com | Lisa Lancaster |Carlo Albera |Williamson Z. Bradford |Ulrich Costabel

Interstitial lung disease Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Jun 27, 2024 | bmjopenrespres.bmj.com | Lisa Lancaster |Bruno Crestani |Paul Hernandez |Yoshikazu Inoue

Interstitial lung disease Safety and survival data in patients with idiopathic pulmonary fibrosis treated with nintedanib: pooled data from six clinical trials Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.